glp 1 not working does work for some people Are you currently taking a GLP-1? Many Why GLP-1 Treatments Might Not

Zilleruelo, G., Novak, M., Hsia, S

doi: 10.1186/s13075-022-02899-3 168 SlominskiAZbytekBSemakISweatmanTWortsmanJ

The consequences are significant: accelerated muscle loss, a soft flabby appearance despite weight loss, reduced metabolic rate, weakened immune function, hair loss, and poor recovery from exercise

Reported protocols from research settings and case literature include: Subcutaneous self-injection at doses of 0.5-1 mg Loading phase protocols followed by maintenance dosing Typical research doses of 0.025 mg/kg in clinical studies No standardized reconstitution or storage protocols in unregulated use The self-administration model and lack of pharmaceutical-grade products create additional safety risks absent from the Melanotan-1 paradigm